STOCK TITAN

ALTAMIRA THERAPEUTICS (CYTOF) EPS by Year

CYTOF OTC

ALTAMIRA THERAPEUTICS LTD lost $2.99 per diluted share in fiscal year 2024. The table below carries 6 fiscal years, from 2018 to 2024, and the quarters ALTAMIRA THERAPEUTICS LTD has filed alongside them.

FY2024 annual
EPS (Diluted) -$2.99
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2025, ended Jun 30, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CYTOF EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2410-KFY2310-KFY2210-KFY2010-KFY1910-KFY1810-K
EPS (Diluted)-$2.99-$8.77-$610.03N/AN/AN/A

CYTOF EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2510-KQ4'2410-KQ2'2410-QQ4'2310-KQ4'2210-K
EPS (Diluted)N/AN/AN/AN/AN/A

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More ALTAMIRA THERAPEUTICS LTD financials

Frequently Asked Questions

What was ALTAMIRA THERAPEUTICS LTD's diluted earnings per share in fiscal year 2024?

ALTAMIRA THERAPEUTICS LTD lost $2.99 per diluted share in fiscal year 2024.

What does diluted earnings per share mean on a financial statement?

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what ALTAMIRA THERAPEUTICS LTD (CYTOF) reported on that line in every period on record.